Comparison of Allergic Rhinitis Treatments on Patient Satisfaction: A MASK ‐air and EAACI Methodological Committee Report
Allergy · 2025
DOI: 10.1111/all.70055 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Allergy, 2025. Verfasst von Bernardo Sousa-Pinto und 45 weiteren Autor:innen. Beteiligte Einrichtung: MEDCIDS-Department of Community Medicine, Information and Health Decision Sciences, Faculty of Medicine, University of Porto, Porto, Portugal. Hauptthemen laut MEDLINE: Patient Satisfaction, Rhinitis, Allergic, Anti-Allergic Agents. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: MASK-air SAS, European Academy of Allergy and Clinical Immunology.
Abstract (Originalsprache)
Introduction
Satisfaction with treatments may affect medication adherence and use patterns, including the use of co‐medication. We aimed to compare different medications for allergic rhinitis (AR) on (i) patients' satisfaction and (ii) co‐medication use frequency.
Methods
We assessed data from the mHealth app MASK‐air. We evaluated days on which users with self‐reported AR had used—alone or in co‐medication—intranasal corticosteroids (INCS), intranasal antihistamines (INAH), fixed combinations of INAH+INCS, or oral antihistamines (OAH). We built multivariable regression models to compare these different AR medication classes (as well as individual medications) on their (i) treatment satisfaction levels (measured using a specific daily visual analogue scale [‘VAS satisfaction’]) and (ii) odds of being used in co‐medication.
Results
We assessed 28,177 days reported by 1691 MASK‐air users. For all medication classes, co‐medication usage was associated with lower treatment satisfaction. When used in monotherapy, OAH were associated with lower VAS satisfaction than INCS (−1.7 points; 95% CI = –2.7; –0.7) or INAH+INCS (−2.1 points; 95% CI = –3.5; –0.7). INCS displayed higher odds of being used in co‐medication than OAH (OR = 1.3; 95% CI = 1.0; 1.6) or INAH+INCS (OR = 1.3; 95% CI = 0.8; 1.8). When comparing individual intranasal medications, fluticasone furoate and fluticasone propionate tended to be more frequently used in co‐medication. Among individual OAH, desloratadine and rupatadine were associated with higher satisfaction, while fexofenadine was more frequently used in co‐medication.
Conclusion
Using patient‐reported data, we evaluated different medication classes and treatments in terms of satisfaction and co‐medication frequency. These results provide key insights into the acceptability of AR treatments and will contribute to future treatment guidelines.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- MEDCIDS-Department of Community Medicine, Information and Health Decision Sciences, Faculty of Medicine, University of Porto, Porto, Portugal.
- CINTESIS@RISE-Health Research Network, Faculty of Medicine, University of Porto, Porto, Portugal.
- Department of Health Research Methods, Evidence, and Impact & Department of Medicine, Evidence in Allergy Group, McMaster University, Hamilton, Ontario, Canada.
- Allergy Unit, Department of Internal Medicine, University Hospital AOU delle Marche, Ancona, Italy.
- Department of Clinical and Molecular Sciences, Marche Polytechnic University, Ancona, Italy.
- Department of Pharmacotherapy and Pharmaceutical Care, Faculty of Pharmacy, Medical University of Warsaw, Warsaw, Poland.
ORCID-Profile: Rafael José Vieira, Antonio Bognanni, Matteo Martini, Michal Ordak, Giovanni Paoletti, Rita Amaral, G Walter Canonica, Álvaro A Cruz, Mattia Giovannini, Ludger Klimek, Marek Niedoszytko, Nikolaos G Papadopoulos, Sanna K Toppila-Salmi, Leticia de Las Vecillas, Yi-Kui Xiang, Oliver Pfaar, Torsten Zuberbier, Jean Bousquet
Förderung
- MASK-air SAS
- European Academy of Allergy and Clinical Immunology
Zitieren
APA
Sousa-Pinto, B., Vieira, R. J., Bognanni, A., Martini, M., Ordak, M., Paoletti, G., Gil-Mata, S., Amaral, R., Bedbrook, A., Bonadonna, P., Brussino, L., Canonica, G. W., Coutinho-Almeida, J., Cruz, Á. A., Czarlewski, W., Dykewicz, M., Giovannini, M., Gemicioglu, B., Ivancevich, J. C., …, & Bousquet, J. (2025). Comparison of Allergic Rhinitis Treatments on Patient Satisfaction: A MASK ‐air and EAACI Methodological Committee Report. Allergy. https://doi.org/10.1111/all.70055
Vancouver
Sousa-Pinto B, Vieira RJ, Bognanni A, Martini M, Ordak M, Paoletti G, et al. Comparison of Allergic Rhinitis Treatments on Patient Satisfaction: A MASK ‐air and EAACI Methodological Committee Report. Allergy. 2025. doi:10.1111/all.70055
BibTeX
@article{SousaPinto2025,
author = {Sousa-Pinto, Bernardo and Vieira, Rafael José and Bognanni, Antonio and Martini, Matteo and Ordak, Michal and Paoletti, Giovanni and Gil-Mata, Sara and Amaral, Rita and Bedbrook, Anna and Bonadonna, Patrizia and Brussino, Luisa and Canonica, G Walter and Coutinho-Almeida, João and Cruz, Álvaro A and Czarlewski, Wienczyslawa and Dykewicz, Mark and Giovannini, Mattia and Gemicioglu, Bilun and Ivancevich, Juan Carlos and Klimek, Ludger and Kvedariene, Violeta and Larenas-Linnemann, Desiree E and Marques-Cruz, Manuel and Moreira, André and Niedoszytko, Marek and Pereira, Ana Margarida and Papadopoulos, Nikolaos G and Pham-Thi, Nhan and Regateiro, Frederico S and Toppila-Salmi, Sanna K and Samolinski, Boleslaw and Sastre, Joaquin and Taborda-Barata, Luís and Thomander, Tuuli and Koyuncu, Ilgım Vardaloğlu and Valiulis, Arunas and Vecillas, Leticia de Las and Ventura, Maria Teresa and Walusiak-Skorupa, Jolanta and Xiang, Yi-Kui and Pfaar, Oliver and Fonseca, João A and Zuberbier, Torsten and Schünemann, Holger J and di Bona, Danilo and Bousquet, Jean},
title = {Comparison of Allergic Rhinitis Treatments on Patient Satisfaction: A MASK ‐air and EAACI Methodological Committee Report},
journal = {Allergy},
year = {2025},
doi = {10.1111/all.70055}
}
EUVIMED